Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis

Brain

Volumn 123, Issue 7, 2000, Pages 1339-1348

  Vielhaber, Stefan ^a   Kunz, Dagmar ^b   Winkler, Kirstin ^a   Wiedemann, Falk R ^a   Kirches, Elmar ^a   Feistner, Helmut ^a   Heinze, Hans Jochen ^a   Elger, Christian E ^c   Schubert, Walter ^a   Kunz, Wolfram S ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF AACHEN MEDICAL CENTER   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Mitochondria; Mitochondrial DNA damage; Mn SOD; Oxidative phosphorylation; Oxygen radicals; Sporadic amyotrophic lateral sclerosis

Indexed keywords

CYTOCHROME C OXIDASE; FLAVOPROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; OXYGEN RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SAPONIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELL; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FLUORESCENCE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGING; MALE; MITOCHONDRION; MOLECULAR BIOLOGY; MOTONEURON; MUSCLE BIOPSY; MUSCLE CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY CHAIN; SKELETAL MUSCLE; SPINAL CORD;

EID: 0033917463     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.7.1339     Document Type: Article

References (34)

1. Beal MF. Aging, energy and oxidative stress in neurodegenerative diseases. [Review]. Ann Neurol 1995; 38: 357-66.
2. Bergmeyer HU. Methoden der enzymatischen Analyse. 2nd edn. Weinheim: Verlag Chemie; 1970.
3. Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322-5.
4. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124 Suppl: 96-107.
5. Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM, et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 1995; 6: 349-62.
6. Comi GP, Bordoni A, Salani S, Franceschina L, Sciacco M, Prelle A, et al. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 1998; 43: 110-6.
7. Dubowitz V, Brooke MH. Muscle biopsy. A modern approach. Philadelphia: W.B. Saunders; 1973.
8. Emery AE. Population frequencies of neuromuscular diseases - II. Amyotrophic lateral sclerosis (motor neurone disease). [Review]. Neuromuscul Disord 1991; 1: 323-5.
9. Fridovich I. Superoxide dismutases. [Review]. Annu Rev Biochem 1975; 44: 147-59.
10. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-9.
11. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 1998; 18: 687-97.
12. Klivenyi P, Ferrante RJ, Matthews RT Bogdanov MB, Klein AM, Andreassen OA, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med 1999; 5: 347-50.
13. Kunz WS, Kuznetsov AV, Schulze W, Eichhorn K, Schild L, Striggow F, et al. Functional characterization of mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers. Biochim Biophys Acta 1993; 1144: 46-53.
14. Kuznetsov AV, Mayboroda O, Kunz D, Winkler K, Schubert W, Kunz WS. Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. J Cell Biol 1998; 140: 1091-9.
15. Ludolph AC, Hugon J, Dwivedi MP, Schaumburg HH, Spencer PS. Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases. Brain 1987; 110: 149-65.
16. Mayevsky A, Chance B. Intracellular oxidation-reduction state measured in situ by a multichannel fiber-optic surface fluorometer. Science 1982; 217: 537-40.
17. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci USA 1999; 96: 846-51.
18. Meyer T, Lenk U, Kuther G, Weindl A, Speer A, Ludolph AC. Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosis. Ann Neurol 1995; 37: 817-9.
19. Meyer T, Speer A, Meyer B, Sitte W, Kuther G, Ludolph AC. The glial glutamate transporter complementary DNA in patients with amyotrophic lateral sclerosis. Ann Neurol 1996; 40: 456-59.
20. Mitsui T, Kawai H, Nagasawa M, Kunishige M, Akaike M, Kimura Y, et al. Oxidative damage to skeletal muscle DNA from patients with mitochondrial encephalomyopathies. J Neurol Sci 1996; 139: 111-6.
21. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA 1996; 93: 5472-7.
22. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
23. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326: 1464-8.
24. Saks VA, Veksler VI, Kuznetsov AV, Kay L, Sikk P, Tiivel T, et al. Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem 1998; 184: 81-100.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, Vol. 2. 2nd edn. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1989.
26. Sasaki S, Iwata M. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett 1996; 204: 53-6.
27. Shoubridge EA, Karpati G, Hastings KE. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 1990; 62: 43-9.
28. Skulachev VP. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. [Review]. Q Rev Biophys 1996; 29: 169-202.
29. Smith RG, Henry YK, Mattson MP, Appel SH. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 696-9.
30. Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987; 237: 517-22.
31. Tritschler H-J, Andreetta F, Moraes CT, Bonilla E, Arnaudo E, Danon MJ, et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 1992; 42: 209-17.
32. Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 1998; 156: 65-72.
33. Wilson RB, Roof DM. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nature Genet 1997; 16: 352-7.
34. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-16.